Cargando…
High Throughput Screening Targeting the Dengue NS3-NS5 Interface Identifies Antivirals against Dengue, Zika and West Nile Viruses
Dengue virus (DENV) threatens almost 70% of the world’s population, with no effective therapeutic currently available and controversy surrounding the one approved vaccine. A key factor in dengue viral replication is the interaction between DENV nonstructural proteins (NS) 5 and 3 (NS3) in the infect...
Autores principales: | Yang, Sundy N. Y., Maher, Belinda, Wang, Chunxiao, Wagstaff, Kylie M., Fraser, Johanna E., Jans, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870125/ https://www.ncbi.nlm.nih.gov/pubmed/35203378 http://dx.doi.org/10.3390/cells11040730 |
Ejemplares similares
-
Structure‐Based Macrocyclization of Substrate Analogue NS2B‐NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses
por: Braun, Niklas J., et al.
Publicado: (2020) -
Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication
por: Kouretova, Jenny, et al.
Publicado: (2017) -
Specificity of Dengue NS1 Antigen in Differential Diagnosis of Dengue and Zika Virus Infection
por: Matheus, Séverine, et al.
Publicado: (2016) -
The inability of a dengue NS1 ELISA to detect Zika infections
por: Lima, Monique da Rocha Queiroz, et al.
Publicado: (2019) -
Dengue, West Nile virus, chikungunya, Zika—and now Mayaro?
por: Hotez, Peter J., et al.
Publicado: (2017)